Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges S Basavaraj, GV Betageri Acta Pharmaceutica Sinica B 4 (1), 3-17, 2014 | 116 | 2014 |
Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol S Basavaraj, GV Betageri Expert opinion on drug delivery 11 (4), 493-503, 2014 | 65 | 2014 |
Development of a chitosan‐based nanoparticle formulation for delivery of a hydrophilic hexapeptide, dalargin Y Chen, B Siddalingappa, PHH Chan, HAE Benson Peptide Science 90 (5), 663-670, 2008 | 52 | 2008 |
Stabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability … B Siddalingappa, HAE Benson, DH Brown, KT Batty, Y Chen Plos one 10 (3), e0118824, 2015 | 26 | 2015 |
Bioavailability enhancement of poorly water soluble and weakly acidic new chemical entity with 2-hydroxy propyl-β-cyclodextrin: selection of meglumine, a polyhydroxy base, as a … S Basavaraj, V Sihorkar, TR Shantha Kumar, P Sundaramurthi, ... Pharmaceutical development and technology 11 (4), 443-451, 2006 | 26 | 2006 |
Insoluble drug delivery technologies: review of health benefits and business potentials B Siddalingappa, V Nekkanti, GV Betageri OA Drug Design & Delivery 1 (1), 1, 2013 | 18 | 2013 |
Comparative pharmacokinetic data of DRF-4367 using nanosuspension and HP-B-CD formulation TR Shanthakumar, S Prakash, RM Basavraj, M Ramesh, R Kant, ... Proceedings of the International Symposium on Advances in Technology and …, 2004 | 13 | 2004 |
Application of solvent influenced fluorescence-quenching and enhancement to develop a highly sensitive HPLC methodology for analysis of resveratrol-PEG conjugates S Basavaraj, H Ann Elizabeth Benson, D Havelock Brown, Y Chen Current Pharmaceutical Analysis 9 (2), 199-207, 2013 | 8 | 2013 |
Development of a liquid chromatography/mass spectrometry methodology to separate, detect, characterize and quantify PEG‐resveratrol prodrugs and the conjugation reaction … S Basavaraj, HAE Benson, C Cruickshank, DH Brown, Y Chen Rapid Communications in Mass Spectrometry 25 (11), 1543-1551, 2011 | 8 | 2011 |
Evaluation of various processes for simultaneous complexation and granulation to incorporate drug–cyclodextrin complexes into solid dosage forms V Gyanani, B Siddalingappa, GV Betageri Drug Development and Industrial Pharmacy 41 (11), 1856-1863, 2015 | 5 | 2015 |
Novel formulation strategies to improve solubility and pharmacokinetic profile of Resveratrol S Basavaraj, HAE Benson, DH Brown, Y Chen Controlled Release Society, Product Development Forum, Poorly Soluble Drugs …, 2011 | 3 | 2011 |